Filter announcements
Loading...
Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.
Poly Medicure kicked off FY27 strong! Q1 consolidated revenue surged 30.3% YoY to 525.4 Cr, driven by robust international sales (+36.7%) and steady domestic growth (+16.2%). Infusion Therapy still leads (50% revenue), but Cardiology exploded +897% thanks to strategic acquisitions and domestic push. Renal segment saw pricing challenges. Strategy-wise, Polymed...
Poly Medicure reported FY26 consolidated revenue of Rs 1,875.3 Cr, up 12.3% YoY, driven by strong domestic (+19.6%) and international (+9.3%) sales. Consolidated PAT slightly declined to Rs 320.7 Cr (-5.3%), with Q4 EBITDA margins impacted by recent acquisitions and one-time costs. Standalone performance showed stable revenue (+3.8%) and PAT...
**Business Performance:** Consolidated revenue for FY26 was up 12.3% YoY to 1,875 Cr. Domestic sales jumped 19.6%, and international revenue grew 9.3%, with standalone Q4 hitting a new record. Renal care and 'Others' segments showed strong growth. **Growth Strategy:** Acquisitions like Citieffe (Orthopaedics) and PendraCare (Cardiology) are expanding market &...
Poly Medicure posted solid 9M FY26 consolidated revenue of Rs 1340.7 Cr, up 9.1% year-on-year, with net profit rising 3.6% to Rs 255.7 Cr. Domestic sales were a key driver, surging 17.6%, while international growth also contributed. Infusion Therapy remains the largest segment, making up 60% of revenue. The company...
Poly Medicure posted solid Q3 FY26 consolidated revenue growth of 16.4% to Rs 493.7 Cr, with 9M FY26 revenue up 9.1% to Rs 1340.7 Cr. Domestic revenue soared 16.2% in Q3, while international revenue also saw robust growth, notably 25.7% in Europe. The 'Others' segment led overall growth, jumping 40.6%...